youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
ILMN:NASDAQ
Illumina Inc
$277.00
arrow_upward
+2.20%(+5.95) 1D
Oct 27, 10:28:15 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ILMN...
Open
$269.42
High
$278.00
Low
$266.20
Mkt. cap
41.55B
Avg. vol.
3.69M
Volume
213.90K
P/E ratio
51.15
52-wk high
$309.34
52-wk low
$94.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
Open
$269.42
High
$278.00
Low
$266.20
Mkt. cap
41.55B
Avg. vol.
3.69M
Volume
213.90K
P/E ratio
51.15
52-wk high
$309.34
52-wk low
$94.00
EPS
$5.38
Beta
1.41
Shares outstanding
151.00M
No. of employees
9K
News stories
From web sources and news partners
investingLive
·
1 hour ago
S&P 500 rebounds as US-Iran escalation fears fade, but bearish drivers remain intact. What's next?
TradingView
·
54 minutes ago
The Dow Jones Index Opens 0.01% Lower
The Motley Fool
·
1 hour ago
Up 16% This Year, How Long Can Procter & Gamble Continue Outperforming the S&P 500?
KuCoin
·
5 hours ago
Calm index, painful "October" for hedge funds _/ Under the s
Profile
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
Illumina's customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Wikipedia
About Illumina Inc
CEOJacob Thaysen
Employees8.62K
Founded1998
HeadquartersSan Diego, California, United States
SectorHealth care
Websiteillumina.com